(Q43187116)

15 November 2017

title

Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis (English)

1 reference

15 November 2017

1 reference

5

Andrej Tarkowski

1 reference

15 November 2017

Björn Svensson

1

1 reference

15 November 2017

Ingiäld Hafström

2

1 reference

15 November 2017

Kristina Forslind

3

1 reference

15 November 2017

Kristina Albertsson

4

1 reference

15 November 2017

Maria Bokarewa

6

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

42

1 reference

15 November 2017

issue

1

1 reference

15 November 2017

page(s)

45-54

1 reference

The costs of rheumatoid arthritis: an international long-term view

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Survivin: a promising tumor biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Targeting survivin in cancer therapy: fulfilled promises and open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903376280

10.3109/07853890903376280

21 January 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference